Prevention of bone loss by phloridzin, an apple polyphenol, in ovariectomized rats under inflammation conditions

Calcified Tissue International

Volumn 77, Issue 5, 2005, Pages 311-318

  Puel, C ^a   Quintin, A ^a   Mathey, J ^a   Obled, C ^a   Davicco, M J ^a   Lebecque, P ^a   Kati Coulibaly, S ^a,b   Horcajada, M N ^a   Coxam, V ^a  

^a CEMAGREF   (France)

^b UNIVERSITÉ FÉLIX HOUPHOUËT BOIGNY   (Côte d’Ivoire)

Author keywords

Bone sparing effect; Inflammation; Ovariectomized rat; Phloridzin

Indexed keywords

BIOLOGICAL MARKER; DEOXYPYRIDINOLINE; FLAVONOID; OROSOMUCOID; OSTEOCALCIN; PHLORIZIN; POLYPHENOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APPLE; ARTICLE; AUTOPSY; BONE ATROPHY; BONE DENSITY; BONE REMODELING; CASTRATION; CONTROLLED STUDY; DIAPHYSIS; DISEASE EXACERBATION; FEMALE; INFLAMMATION; METAPHYSIS; NONHUMAN; OSTEOPENIA; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; RAT STRAIN; SPLEEN WEIGHT; URINARY EXCRETION; URINE LEVEL;

ANIMALS; BODY WEIGHT; BONE DENSITY; BONE DISEASES, METABOLIC; BONE RESORPTION; DISEASE MODELS, ANIMAL; FEMALE; FEMUR; INFLAMMATION; MALUS; ORGAN SIZE; OSTEOCALCIN; OVARIECTOMY; PHLORHIZIN; PLANT EXTRACTS; RATS; RATS, WISTAR; STRESS, MECHANICAL; WEIGHT-BEARING;

EID: 28244449311     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-005-0060-5     Document Type: Article

References (38)

1. Lindsay R (1992) The growing problem of osteoporosis. Osteoporosis Int 2:267-268
2. Ralston SH (1994) Analysis of gene expression in human bone biopsies by polymerase chain reaction: evidence for enhanced cytokine expression in postmenopausal osteoporosis. J Bone Miner Res 9:883-890
3. Pacifici R (1998) Cytokines, estrogen, and postmenopausal osteoporosis - the second decade. Endocrinology 139:2659-2661
4. Santos-Eggimann B (1997) Demographic trends: implications for prevention in the female population. Ther Umsch 54:431-435
5. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E, HERS I (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280:605-613
6. Hulley S, Furberg C, Barrett-Connor E, Cauley J, Grady D, Haskell W, Knopp R, Lowery M, Satterfield S, Schrott H, Vittinghoff E, Hunninghake D, HERS II (2002) Noncardiovascular disease outcomes during 6.8 years of hormone therapy. JAMA 288:58-66
7. Lacey JV, Mink PJ, Lubin JH, Sherman ME, Troisi R, Hartge P, Schatzkin A, Schairer C (2002) Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 288:334-341
8. Million Women Study (MWS) Collaborators (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362:419-427
9. Macdonald HM, New SA, Golden MH, Campbell MK, Reid DM (2004) Nutritional associations with bone loss during the menopausal transition: evidence of a beneficial effect of calcium, alcohol, and fruit and vegetable nutrients and of a detrimental effect of fatty acids. Am J Clin Nutr 9:155-165
10. Horcajada-Molteni MN, Coxam V (2001) Flavonols and isoflavones prevent bone loss in the ovariectomized rat, a model for postmenopausal osteoporosis. In: Burkhardt F, Dawson-Hughes B, Heaney RP (eds) Nutritional aspects of osteoporosis. Academic Press, San Diego, pp 325-340
11. Wattel A, Kamel S, Mentaverri R, Lorget F, Prouillet C, Petit JP, Fardelonne P, Brazier M (2003) Potent inhibitory effect of naturally occurring flavonoids quercetin and kaempferol on in vitro osteoclastic bone resorption. Biochem Pharmacol 65:35-42
12. Robbins SP (1994) Biochemical markers for assessing skeletal growth. Eur J Clin Nutr 48:5199-8209
13. Pastoureau P, Chomel A, Bonnet J (1995) Specific evaluation of localized bone mass and bone loss in the rat using dual energy X-ray absorptiometry subregional analysis. Osteoporos Int 5:143-149
14. Cook JGH (1975) Factors influencing the assay of creatinine. Ann Clin Biochem 12:219-232
15. Breuille D, Arnal M, Rambourdin F, Bayle G, Levieux D, Obled C (1998) Sustained modifications of protein metabolism in various tissues in a rat model of long-lasting sepsis. Clin Sci (Colch) 94:413-423
16. Kalu DN (1991) The ovariectomized rat model of post-menopausal bone loss. Bone Miner 15:175-191
17. Bruunsgaard H, Pedersen M, Pedersen BK (2001) Aging and proinflammatory cytokines. Curr Opin Hematol 8:131-136
18. Minne HW, Pfeilschifter J, Scharla S, Mutschelknauss S, Schwarz A, Krempien B, Ziegler R (1984) Inflammation-mediated osteopenia in the rat: a new animal model for pathological loss of bone mass. Endocrinology 115:50-54
19. Richard CD, Gauldie J (1995) Role of cytokines in acute-phase response. In: Aggarwal BB, Puri RK (eds) Human cytokines: their role in disease and therapy. Blackwell Science, Cambridge, pp 253-269
20. Cuzzocrea S, Santagati S, Sautebin L, Mazzon E, Calabro I, Caputi AP, Maggi A (2000) 17Beta-estradiol antiinflammatory activity in carrageenan-induced pleurisy. Endocrinology 141:1455-1463
21. Marusic A, Kos K, Stavljenic A, Vukicevic S (1990) Talc granulomatosis in the rat. Involvement of bone in the acute-phase response. Inflammation 14:205-216
22. Fournier T, Medjoubi N, Porquet D (2000) Alpha-1-acid glycoprotein. Biochim Biophys Acta 1482:157-171
23. Vukicevic S, Marusic A, Stavljenic A, Cesnjaj M, Ivankovic D (1994) The role of tumor necrosis factor- alpha in the generation of acute phase response and bone loss in rats with talc granulomatosis. Lab Invest 70:386-391
24. Krempien B, Vukicevic S, Vogel M, Stavljenic A, Buchele R (1988) Cellular basis of inflammation-induced osteopenia in growing rats. J Bone Miner Res 3:573-582
25. Escarpa A, Gonzalez MC (1998) High-performance liquid chromatography with diode-array detection for the determination of phenolic compounds in peel and pulp from different apple varieties. J Chromatogr A 823:331-337
26. Calliste CA, Le Bail JC, Trouillas P, Pouget C, Habrioux G, Chulia AJ, Duroux JL (2001) Chalcones: structural requirements for antioxidant, estrogenic and antiproliferative activities. Anticancer Res 21:3949-3956
27. Miksicek RJ (1993) Commonly occurring plant flavonoids have estrogenic activity. Mol Pharmacol 44:37-43
28. Fritsche S, Steinhart H (1999) Occurrence of hormonally active compounds in food: a review. Eur Food Res Technol 209:153-179
29. Coxam V, Bowman BM, Mecham M, Roth CM, Miller MA, Miller SC (1996) Effects of dihydrotes-tosterone alone and combined with estrogen on bone mineral density, bone growth and formation rates in ovariectomized rats. Bone 19:107-114
30. Arjmandi BH, Birnbaum RS, Juma S, Barengolts E, Kukreja SC (2000) The synthetic phytoestrogen, ipriflavone, and estrogen prevent bone loss by different mechanisms. Calcif Tissue Int 66:61-65
31. Picherit C, Bennetau-Pelissero C, Chanteranne B, Lebecque P, Davicco MJ, Barlet JP, Coxam V (2001) Soybean isoflavones dose-dependently reduce bone turnover but do not reverse established osteopenia in adult ovariectomized rats. J Nutr 131:723-728
32. Fanti P, Monier-Faugere MC, Geng Z, Schmidt J, Morris PE, Cohen D, Malluche HH (1998) The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats. Osteoporos Int 8:274-281
33. Coxam V, Bowman BM, Mecham M, Roth CM, Miller MA, Miller SC (1996) Effects of dihydrotes-tosterone alone and combined with estrogen on bone mineral density, bone growth, and formation rates in ovariectomized rats. Bone 19:107-114
34. Ridgway T, O'Reilly J, West G, Tucker G, Wiseman H (1996) Potent antioxidant properties of novel apple-derived flavonoids with commercial potential as food additives. Biochem Soc Trans 24:39S
35. Garrett IR, Boyce BF, Oreffo RO, Bonewald L, Poser J, Mundy GR (1990) Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest 85:632-639
36. Mody N, Parhami F, Sarafian TA, Demer L (2001) Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med 31:509-519
37. Seifert MF, Watkins BA (1997) Role of dietary lipid and antioxidants in bone metabolism. Nutr Res 17:1209-1228
38. 2 on bone formation in cultured fetal rat calvaria: interaction with cortisol. Endocrinology 126:1654-1659